Clinical trial

Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer

NCT06795529

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-10-01

PhaseNA

Study timeline

Study start (actual)2025-10-01Date precision: day

Registry last updated2025-11-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Breast Cancerunresolved

Interventions

Palliative Care Intervention, "TARGET-PC"OTHER

Enhanced Usual CareOTHER

Sponsors & collaborators

Massachusetts General Hospitallead sponsor

National Cancer Institute (NCI)collaborator

Duke Universitycollaborator

University of Pennsylvaniacollaborator

Mapped research locations

BostonMassachusetts, United States1 PhiladelphiaPennsylvania, United States1 DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06795529 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.